wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47914370-5BBEBC50-DB91-4ED5-B365-EFA9FEB8DC09
Q47914370-5BBEBC50-DB91-4ED5-B365-EFA9FEB8DC09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47914370-5BBEBC50-DB91-4ED5-B365-EFA9FEB8DC09
Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study.
P2860
Q47914370-5BBEBC50-DB91-4ED5-B365-EFA9FEB8DC09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47914370-5BBEBC50-DB91-4ED5-B365-EFA9FEB8DC09
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bc1002861d10cea8a8343b57f3e29780fb9a02ba
P2860
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.